|
|
Article: EP MedSystems Announces FDA Market Clearance for New EP-4 Cardiac Stimulation System.
- Article from:
- Business Wire
- Article date:
- March 4, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
WEST BERLIN, N.J.--(BUSINESS WIRE)--March 4, 2004
EP MedSystems, Inc. (NASDAQ: EPMD), a market leader in electrophysiology products used to diagnose and treat certain types of cardiac rhythm disorders, today announced the FDA market clearance for its new EP-4(TM) Computerized Cardiac Stimulator. The EP-4 offers further advancements in cardiac stimulation, which is an essential component of nearly all electrophysiology ("EP") procedures to diagnose and treat certain cardiac rhythm disorders. EP MedSystems also has received regulatory approval from its European Notified Body for the EP-4, allowing the sale of the ...